http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080057751-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77cda1c2a325a9109bcd586925f45da8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e474aa7aeefafb2cc3faf1cbbf3ff26 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-22 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-48 |
| filingDate | 2006-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a04cced8a366108b111b1123ebcd8b3 |
| publicationDate | 2008-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20080057751-A |
| titleOfInvention | Codon-optimized NC polynucleotides of HIV, vectors containing the polynucleotides, and methods of producing NC proteins using the same |
| abstract | The present invention relates to a codon-optimized NC polynucleotide of HIV, a vector comprising the polynucleotide and a method of producing NC protein using the same. More specifically, the present invention provides a method of conjugating mRNA stabilizing factors underneath a codon-optimized NC polynucleotide, an intron sequence and the codon-optimized NC polynucleotide, or a codon-optimized NC polynucleotide underneath. The present invention relates to a vector for NC protein expression of HIV and a method for producing NC protein using the same, wherein mRNA stability elements are additionally linked.n n n The codon-optimized NC polynucleotide of the present invention and the NC protein expression vector of HIV comprising the same can express a wild type NC protein in an animal cell, and its expression efficiency is improved compared to the prior art. It can be used for the development of antiviral agents effective for HIV. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019240429-A1 |
| priorityDate | 2006-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 400.